Agenus (AGEN) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Agenus (AGEN)

AGEN 3.965

-0.1%

Nov 3 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Area51 who wrote (7)	2/2/2004 8:48:28 PM
From: Area51	of 146

I came across this in researching drugs being developed for RCC. It lists drugs in development for RCC and summarizes trial results where available. centerwatch.com Oncophage seemed to have the most populated studies (and was the only one where it indicated success in stage IV RCC). Is it fair to conclude that Oncophage has good prospects for commercialization for RCC? It seems to work better than any other available drugs so if I had stage IV RCC I think I would want Oncophage approved ASAP (albeit only a 1 in three chance that it would save me(disease stabilization or better)?

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next